SGLT2 inhibitor (redirect from Gliflozins)
SGLT2 inhibitors (also called gliflozins or flozins) are a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional...
44 KB (4,559 words) - 22:03, 7 July 2024
Gliflozins are a class of drugs in the treatment of type 2 diabetes (T2D). They act by inhibiting sodium/glucose cotransporter 2 (SGLT-2), and are therefore...
26 KB (3,188 words) - 18:13, 22 September 2024
2 diabetes. Gliflozins enhance glycemic control as well as reduce body weight and systolic and diastolic blood pressure. The gliflozins canagliflozin...
8 KB (853 words) - 17:51, 22 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
68 KB (5,595 words) - 15:33, 1 October 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
44 KB (3,493 words) - 05:47, 15 September 2024
condition is then labeled "ketosis-prone type 2 diabetes". Drugs in the gliflozin class (SGLT2 inhibitors), which are generally used for type 2 diabetes...
44 KB (5,086 words) - 23:38, 11 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
3 KB (184 words) - 13:53, 14 June 2024
improve the glycemic control. Henagliflozin, like other drugs of the gliflozin class, inhibits the transporter protein sodium/glucose cotransporter 2...
4 KB (189 words) - 11:18, 12 May 2024
vitamins, and short-chain fatty acids. SGLT2 inhibitors, also called gliflozins, are used in the treatment of type 2 diabetes. SGLT2 is only found in...
10 KB (969 words) - 18:19, 22 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
4 KB (328 words) - 05:24, 6 August 2024
ketoacidosis. Possible cardiovascular problems are an ongoing issue with gliflozin drugs. The pre-specified endpoint for cardiovascular safety in the canagliflozin...
29 KB (2,960 words) - 20:56, 4 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
9 KB (284 words) - 09:11, 17 June 2024
cotransporter 2 (SGLT2) inhibitor and is in the class of drugs known as gliflozins. In the United States, it was approved by the Food and Drug Administration...
12 KB (888 words) - 02:32, 16 July 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
26 KB (3,386 words) - 20:05, 10 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
16 KB (1,542 words) - 20:53, 21 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
41 KB (3,673 words) - 18:02, 22 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
151 KB (14,463 words) - 00:39, 30 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
25 KB (2,738 words) - 14:32, 16 August 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
24 KB (1,877 words) - 21:09, 21 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
11 KB (760 words) - 13:42, 7 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
53 KB (4,975 words) - 03:43, 30 September 2024
urine producing glycosuria. Additionally, SGLT2 inhibitor medications ("gliflozins" or "flozins") produce glycosuria as their primary mechanism of action...
6 KB (560 words) - 05:20, 19 August 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
18 KB (1,514 words) - 15:51, 7 June 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
7 KB (479 words) - 11:42, 6 August 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
38 KB (3,935 words) - 21:33, 20 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
24 KB (2,087 words) - 16:42, 11 May 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
20 KB (1,637 words) - 08:06, 7 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
10 KB (748 words) - 23:39, 16 August 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
7 KB (414 words) - 03:09, 2 September 2024
Alpha-glucosidase inhibitors Acarbose Miglitol Voglibose SGLT2 inhibitors/"gliflozins" Canagliflozin Dapagliflozin Empagliflozin# Ertugliflozin Ipragliflozin...
4 KB (275 words) - 18:01, 26 April 2024